These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 6204725

  • 1. Calcium channel 'agonist' BAY K 8644 inhibits calcium antagonist binding to brain and PC12 cell membranes.
    Greenberg DA, Cooper EC, Carpenter CL.
    Brain Res; 1984 Jul 09; 305(2):365-8. PubMed ID: 6204725
    [Abstract] [Full Text] [Related]

  • 2. Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain.
    Janis RA, Rampe D, Sarmiento JG, Triggle DJ.
    Biochem Biophys Res Commun; 1984 May 31; 121(1):317-23. PubMed ID: 6203531
    [Abstract] [Full Text] [Related]

  • 3. Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent [3H]noradrenaline release from PC 12 cells.
    Albus U, Habermann E, Ferry DR, Glossmann H.
    J Neurochem; 1984 Apr 31; 42(4):1186-9. PubMed ID: 6199462
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of calcium uptake in PC12 cells by the dihydropyridine agonist BAY K 8644.
    Greenberg DA, Carpenter CL, Cooper EC.
    J Neurochem; 1985 Sep 31; 45(3):990-3. PubMed ID: 2411863
    [Abstract] [Full Text] [Related]

  • 5. BAY K 8644, a 1,4-dihydropyridine Ca2+ channel activator: dissociation of binding and functional effects in brain synaptosomes.
    Rampe D, Janis RA, Triggle DJ.
    J Neurochem; 1984 Dec 31; 43(6):1688-92. PubMed ID: 6208338
    [Abstract] [Full Text] [Related]

  • 6. The effect of the calcium channel agonist, Bay K-8644 on human vascular smooth muscle.
    Gopalakrishnan V, Park LE, Triggle CR.
    Eur J Pharmacol; 1985 Jul 31; 113(3):447-51. PubMed ID: 2412849
    [Abstract] [Full Text] [Related]

  • 7. In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.
    Rogg H, Criscione L, Truog A, Meier M.
    J Cardiovasc Pharmacol; 1985 Jul 31; 7 Suppl 6():S31-7. PubMed ID: 2414592
    [Abstract] [Full Text] [Related]

  • 8. The behavioral effects of the calcium agonist Bay K 8644 in the mouse: antagonism by the calcium antagonist nifedipine.
    Bolger GT, Weissman BA, Skolnick P.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb 31; 328(4):373-7. PubMed ID: 2581145
    [Abstract] [Full Text] [Related]

  • 9. The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart.
    O'Neill SK, Bolger GT.
    Pharmacol Biochem Behav; 1990 Apr 31; 35(4):833-40. PubMed ID: 1693213
    [Abstract] [Full Text] [Related]

  • 10. Calcium entry activators: distinct sites of dihydropyridine and aminopyridine action.
    Greenberg DA, Cooper EC, Carpenter CL.
    Neurosci Lett; 1984 Sep 07; 50(1-3):279-82. PubMed ID: 6208517
    [Abstract] [Full Text] [Related]

  • 11. Competitive binding experiments reveal differential interactions for dihydropyridine calcium channel activators and antagonists at dihydropyridine receptors on mouse brain membranes.
    O'Neill SK, Triggle CR, Bolger GT.
    Can J Physiol Pharmacol; 1994 Jul 07; 72(7):738-45. PubMed ID: 7530159
    [Abstract] [Full Text] [Related]

  • 12. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
    Janis RA, Sarmiento JG, Maurer SC, Bolger GT, Triggle DJ.
    J Pharmacol Exp Ther; 1984 Oct 07; 231(1):8-15. PubMed ID: 6208356
    [Abstract] [Full Text] [Related]

  • 13. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex.
    Schoemaker H, Langer SZ.
    Eur J Pharmacol; 1985 May 08; 111(2):273-7. PubMed ID: 2410283
    [Abstract] [Full Text] [Related]

  • 14. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
    Bellemann P.
    J Recept Res; 1984 May 08; 4(1-6):571-85. PubMed ID: 6084713
    [Abstract] [Full Text] [Related]

  • 15. A functional correlate for the dihydropyridine binding site in rat brain.
    Middlemiss DN, Spedding M.
    Nature; 1984 May 08; 314(6006):94-6. PubMed ID: 2579341
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO, Carpenter CL, Greenberg DA.
    J Pharmacol Exp Ther; 1985 Nov 08; 235(2):407-11. PubMed ID: 2414431
    [Abstract] [Full Text] [Related]

  • 17. Calcium antagonists High-affinity binding and inhibition of calcium transport in a clonal cell line.
    Toll L.
    J Biol Chem; 1982 Nov 25; 257(22):13189-92. PubMed ID: 6292179
    [Abstract] [Full Text] [Related]

  • 18. Dihydropyridine sensitive calcium channels in a smooth muscle cell line.
    Kongsamut S, Freedman SB, Miller RJ.
    Biochem Biophys Res Commun; 1985 Feb 28; 127(1):71-9. PubMed ID: 2579654
    [Abstract] [Full Text] [Related]

  • 19. Dihydropyridine binding sites regulate calcium influx through specific voltage-sensitive calcium channels in cerebellar granule cells.
    Carboni E, Wojcik WJ.
    J Neurochem; 1988 Apr 28; 50(4):1279-86. PubMed ID: 2450173
    [Abstract] [Full Text] [Related]

  • 20. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
    Williams LT, Tremble P.
    J Clin Invest; 1982 Jul 28; 70(1):209-12. PubMed ID: 6282938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.